Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial

Volume: 16, Issue: 5, Pages: 369 - 376
Published: May 1, 2017
Abstract
Summary null Background null The REVASCAT trial and other studies have shown that the neurovascular thrombectomy improves outcomes at 90 days post stroke. However, whether the observed benefit is sustained in the long term remains unknown. We report the results of the prespecified 12-month analysis of the REVASCAT trial. null Methods null Patients with acute ischaemic stroke who could be treated within 8 h of symptom onset were randomly assigned...
Paper Details
Title
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
Published Date
May 1, 2017
Volume
16
Issue
5
Pages
369 - 376
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.